Scott Mendel, President & CEO at GenMark Diagnostics, Inc. (GNMK), sold 9,064 shares at $14.14 ($128K) on 2020-08-25, disclosed to the SEC on 2020-08-26.
Seasonal sale ($128k) by President & CEO — this insider has traded GNMK in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.14 | 4,532 | $64K | 50.0% |
| 2 | $14.14 | 4,532 | $64K | 50.0% |
| Total | $14.14 avg | 9,064 | $128K | 100% |
| Filing → |
| GNMK | SELL | 2021-01-25 | $1.8M | — | Filing → |
| GNMK | SELL | 2021-01-21 | $727K | — | Filing → |
| GNMK | SELL | 2020-11-25 | $137K | — | Filing → |